NGAL antibody
Rif. 3D-10-1776
| 400µl | 3.295,00 € |
Informazioni sul prodotto
The NGAL antibody is a highly specialized binding protein that targets the necrosis factor-related apoptosis-inducing ligand (TRAIL) and alpha-fetoprotein (AFP). Developed by Life Sciences, this monoclonal antibody is designed to specifically bind to these target molecules in human serum. By binding to TRAIL and AFP, the NGAL antibody inhibits their protease activity and prevents their interaction with receptors on cell surfaces.
This unique antibody has been extensively studied and shown to be effective in various research applications. It has been used in studies investigating signal transduction pathways, such as the PI3-kinase pathway, and its role in cell survival and apoptosis. Additionally, the NGAL antibody has been utilized in research exploring angiogenesis and tumor growth inhibition through its ability to block endothelial growth factors.
Moreover, this monoclonal antibody has demonstrated promising results when used in combination with other therapeutic agents. For instance, it has been found to enhance the efficacy of pomalidomide,
Proprietà chimiche
Richiesta tecnica su: 3D-10-1776 NGAL antibody
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
